Dabigatran Compared With Rivaroxaban vs Warfarin.
Publication
, Journal Article
Vora, AN; Alexander, JH; Lopes, RD
Published in: JAMA Intern Med
May 1, 2017
Duke Scholars
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
May 1, 2017
Volume
177
Issue
5
Start / End Page
742 / 743
Location
United States
Related Subject Headings
- Warfarin
- United States
- Stroke
- Rivaroxaban
- Medicare
- Humans
- Dabigatran
- Atrial Fibrillation
- Aged
- 4203 Health services and systems
Citation
APA
Chicago
ICMJE
MLA
NLM
Vora, A. N., Alexander, J. H., & Lopes, R. D. (2017). Dabigatran Compared With Rivaroxaban vs Warfarin. JAMA Intern Med, 177(5), 742–743. https://doi.org/10.1001/jamainternmed.2017.0561
Vora, Amit N., John H. Alexander, and Renato D. Lopes. “Dabigatran Compared With Rivaroxaban vs Warfarin.” JAMA Intern Med 177, no. 5 (May 1, 2017): 742–43. https://doi.org/10.1001/jamainternmed.2017.0561.
Vora AN, Alexander JH, Lopes RD. Dabigatran Compared With Rivaroxaban vs Warfarin. JAMA Intern Med. 2017 May 1;177(5):742–3.
Vora, Amit N., et al. “Dabigatran Compared With Rivaroxaban vs Warfarin.” JAMA Intern Med, vol. 177, no. 5, May 2017, pp. 742–43. Pubmed, doi:10.1001/jamainternmed.2017.0561.
Vora AN, Alexander JH, Lopes RD. Dabigatran Compared With Rivaroxaban vs Warfarin. JAMA Intern Med. 2017 May 1;177(5):742–743.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
May 1, 2017
Volume
177
Issue
5
Start / End Page
742 / 743
Location
United States
Related Subject Headings
- Warfarin
- United States
- Stroke
- Rivaroxaban
- Medicare
- Humans
- Dabigatran
- Atrial Fibrillation
- Aged
- 4203 Health services and systems